Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT06014164

Qualitative Study About Psychedelics Using in Psychiatric Disorders

Conditions: Psychiatric Disorder

Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 20
Sponsor: University Hospital, Toulouse

Location: University Hospital Toulouse Toulouse

Summary

This study is set up to better understand the current use of psychedelics in France in the general population. The present focus on individuals who have used any type of psychedelic drug in order to suppress or alleviate a psychiatric symptom in the context of a diagnosed pathology. The data are collected during a semi-structured interview and then studied in a thematic analysis.

Eligibility Criteria

Inclusion Criteria: * Patients diagnosed with a psychiatric disorder by a psychiatrist or general practitioner * Patients used psychedelic or related substances in order to treat psychiatric symptoms * Patients have given their oral non-opposition * Patients affiliated to a social security scheme Exclusion Criteria: * Patients who don't speak or understand French * Patients under protection, guardianship or curators

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06014164). StuddyBuddy aggregates publicly available trial information.